Professional Acne Medication Market

1. INTRODUCTION

1.1.           REPORT DESCRIPTION

1.2.           WHO SHOULD READ THIS REPORT 

1.3.           KEY MARKET SEGMENTS

1.4.           RESEARCH METHODOLOGY

1.4.1               SECONDARY RESEARCH

1.4.2               DATA ANALYSIS FRAMEWORK

1.4.3               MARKET SIZE ESTIMATION

1.4.4               FORECASTING

1.4.5               PRIMARY RESEARCH AND DATA VALIDATION

2. PROFESSIONAL ACNE MEDICATION MARKET – EXECUTIVE SUMMARY

2.1.           MARKET SNAPSHOT, 2022 - 2030, MILLION USD

3. MARKET OVERVIEW

3.1.           MARKET DEFINITION AND SCOPE

3.2.           MARKET DYNAMICS

3.2.1               DRIVERS

3.2.1.1.         UNHEALTHY FOOD HABITS AND RISE IN SEDENTARY LIFESTYLES

3.2.1.2.         OCCURRENCE OF ACNE VULGARIS CONDITION IN TEENAGERS & ADULTS

3.2.1.3.         RISING CONSCIOUSNESS ABOUT THE OVERALL APPEARANCE, HEALTH, AND ATTIRE

3.2.2               RESTRAINTS

3.2.2.1.         SIDE-EFFECTS RELATED WITH THE USAGE OF ACNE MEDICATIONS AND SUBSTITUTE ACNE TREATMENT OPTIONS

3.2.3               OPPORTUNITIES

3.2.3.1.         EMERGENCE & DEVELOPMENT OF EFFECTIVE ACNE MEDICATIONS WITH MINOR SIDE EFFECTS

3.2.3.2.         SIGNIFICANT MARKET POTENTIAL IN UNTAPPED DEVELOPING COUNTRIES

4. COVID-19 ANALYSIS

4.1.           IMPACT ON MARKET SIZE

4.2.           END USER TRENDS & PREFERENCES, AND BUDGET & ECONOMIC IMPACT

4.3.           KEY PLAYER STRATEGIES TO TACKLE COVID-19’S INFLUENCE ON MARKET

5. MARKET SHARE ANALYSIS

5.1.           MARKET SHARE ANALYSIS OF TOP ACNE MEDICATION PROVIDERS, 2020

6. TOTAL NUMBER OF MEDICAL SPAS BY COUNTRY

7. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

7.1.           OVERVIEW

7.2.           MED SPA

7.2.1               MED SPA MARKET, BY REGION

7.2.1.1.         NORTH AMERICA MED SPA MARKET, BY COUNTRY

7.2.1.2.         EUROPE MED SPA MARKET, BY COUNTRY

7.2.1.3.         ASIA-PACIFIC MED SPA MARKET, BY COUNTRY

7.2.1.4.         REST OF WORLD MED SPA MARKET, BY COUNTRY

7.3.           ESTHETICIANS

7.3.1               ESTHETICIANS MARKET, BY REGION

7.3.1.1.         NORTH AMERICA ESTHETICIANS MARKET, BY COUNTRY

7.3.1.2.         EUROPE ESTHETICIANS MARKET, BY COUNTRY

7.3.1.3.         ASIA-PACIFIC ESTHETICIANS MARKET, BY COUNTRY

7.3.1.4.         REST OF WORLD ESTHETICIANS MARKET, BY COUNTRY

7.4.           DERMATOLOGIST

7.4.1               DERMATOLOGIST MARKET, BY REGION

7.4.1.1.         NORTH AMERICA DERMATOLOGIST MARKET, BY COUNTRY

7.4.1.2.         EUROPE DERMATOLOGIST MARKET, BY COUNTRY

7.4.1.3.         ASIA-PACIFIC DERMATOLOGIST MARKET, BY COUNTRY

7.4.1.4.         REST OF WORLD DERMATOLOGIST MARKET, BY COUNTRY

7.5.           OTHER PROFESSIONAL CHANNELS

7.5.1               OTHER PROFESSIONAL CHANNELS MARKET, BY REGION

7.5.1.1.         NORTH AMERICA OTHER PROFESSIONAL CHANNELS MARKET, BY COUNTRY

7.5.1.2.         EUROPE OTHER PROFESSIONAL CHANNELS MARKET, BY COUNTRY

7.5.1.3.         ASIA-PACIFIC OTHER PROFESSIONAL CHANNELS MARKET, BY COUNTRY

7.5.1.4.         REST OF WORLD OTHER PROFESSIONAL CHANNELS MARKET, BY COUNTRY

8. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

8.1.           OVERVIEW

8.2.           INFLAMMATORY ACNE

8.2.1               INFLAMMATORY ACNE MARKET, BY REGION

8.2.1.1.         NORTH AMERICA INFLAMMATORY ACNE MARKET, BY COUNTRY

8.2.1.2.         EUROPE INFLAMMATORY ACNE MARKET, BY COUNTRY

8.2.1.3.         ASIA-PACIFIC INFLAMMATORY ACNE MARKET, BY COUNTRY

8.2.1.4.         REST OF WORLD INFLAMMATORY ACNE MARKET, BY COUNTRY

8.3.           NON-INFLAMMATORY ACNE

8.3.1               NON-INFLAMMATORY ACNE MARKET, BY REGION

8.3.1.1.         NORTH AMERICA NON-INFLAMMATORY ACNE MARKET, BY COUNTRY

8.3.1.2.         EUROPE NON-INFLAMMATORY ACNE MARKET, BY COUNTRY

8.3.1.3.         ASIA-PACIFIC NON-INFLAMMATORY ACNE MARKET, BY COUNTRY

8.3.1.4.         REST OF WORLD NON-INFLAMMATORY ACNE MARKET, BY COUNTRY

9. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

9.1.           OVERVIEW

9.2.           RETINOIDS

9.2.1               GLOBAL RETINOIDS MARKET, BY THERAPEUTIC CLASS

9.2.1.1.         TOPICAL RETINOID & COMBINATION RETIONOID  MARKET, BY REGION

9.2.1.1.1.         NORTH AMERICA TOPICAL RETINOID & COMBINATION RETIONOID  MARKET, BY COUNTRY

9.2.1.1.2.         EUROPE TOPICAL RETINOID & COMBINATION RETIONOID  MARKET, BY COUNTRY

9.2.1.1.3.         ASIA-PACIFIC TOPICAL RETINOID & COMBINATION RETIONOID  MARKET, BY COUNTRY

9.2.1.1.4.         REST OF WORLD TOPICAL RETINOID & COMBINATION RETIONOID  MARKET, BY COUNTRY

9.2.1.2.         ORAL RETINOID (ISORETINION) MARKET, BY REGION

9.2.1.2.1.         NORTH AMERICA ORAL RETINOID (ISORETINION) MARKET, BY COUNTRY

9.2.1.2.2.         EUROPE ORAL RETINOID (ISORETINION) MARKET, BY COUNTRY

9.2.1.2.3.         ASIA-PACIFIC ORAL RETINOID (ISORETINION) MARKET, BY COUNTRY

9.2.1.2.4.         REST OF WORLD ORAL RETINOID (ISORETINION) MARKET, BY COUNTRY

9.2.2               RETINOIDS MARKET, BY REGION

9.2.2.1.         NORTH AMERICA RETINOIDS MARKET, BY COUNTRY

9.2.2.2.         EUROPE RETINOIDS MARKET, BY COUNTRY

9.2.2.3.         ASIA-PACIFIC RETINOIDS MARKET, BY COUNTRY

9.2.2.4.         REST OF WORLD RETINOIDS MARKET, BY COUNTRY

9.3.           ANTIBIOTICS

9.3.1               GLOBAL ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

9.3.1.1.         TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET, BY REGION

9.3.1.1.1.         NORTH AMERICA TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET, BY COUNTRY

9.3.1.1.2.         EUROPE TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET, BY COUNTRY

9.3.1.1.3.         ASIA-PACIFIC TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET, BY COUNTRY

9.3.1.1.4.         REST OF WORLD TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET, BY COUNTRY

9.3.1.2.         ORAL ANTIBIOTIC  MARKET, BY REGION

9.3.1.2.1.         NORTH AMERICA ORAL ANTIBIOTIC  MARKET, BY COUNTRY

9.3.1.2.2.         EUROPE ORAL ANTIBIOTIC  MARKET, BY COUNTRY

9.3.1.2.3.         ASIA-PACIFIC ORAL ANTIBIOTIC  MARKET, BY COUNTRY

9.3.1.2.4.         REST OF WORLD ORAL ANTIBIOTIC  MARKET, BY COUNTRY

9.3.2               ANTIBIOTICS MARKET, BY REGION

9.3.2.1.         NORTH AMERICA ANTIBIOTICS MARKET, BY COUNTRY

9.3.2.2.         EUROPE ANTIBIOTICS MARKET, BY COUNTRY

9.3.2.3.         ASIA-PACIFIC ANTIBIOTICS MARKET, BY COUNTRY

9.3.2.4.         REST OF WORLD ANTIBIOTICS MARKET, BY COUNTRY

9.4.           SALICYLIC ACID

9.4.1               SALICYLIC ACID MARKET, BY REGION

9.4.1.1.         NORTH AMERICA SALICYLIC ACID MARKET, BY COUNTRY

9.4.1.2.         EUROPE SALICYLIC ACID MARKET, BY COUNTRY

9.4.1.3.         ASIA-PACIFIC SALICYLIC ACID MARKET, BY COUNTRY

9.4.1.4.         REST OF WORLD SALICYLIC ACID MARKET, BY COUNTRY

9.5.           BENZOYL PEROXIDE

9.5.1               BENZOYL PEROXIDE MARKET, BY REGION

9.5.1.1.         NORTH AMERICA BENZOYL PEROXIDE MARKET, BY COUNTRY

9.5.1.2.         EUROPE BENZOYL PEROXIDE MARKET, BY COUNTRY

9.5.1.3.         ASIA-PACIFIC BENZOYL PEROXIDE MARKET, BY COUNTRY

9.5.1.4.         REST OF WORLD BENZOYL PEROXIDE MARKET, BY COUNTRY

9.6.           OTHERS

9.6.1               OTHERS MARKET, BY REGION

9.6.1.1.         NORTH AMERICA OTHERS MARKET, BY COUNTRY

9.6.1.2.         EUROPE OTHERS MARKET, BY COUNTRY

9.6.1.3.         ASIA-PACIFIC OTHERS MARKET, BY COUNTRY

9.6.1.4.         REST OF WORLD OTHERS MARKET, BY COUNTRY

10. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

10.1.        OVERVIEW

10.2.        TOPICAL MEDICATIONS

10.2.1             TOPICAL MEDICATIONS MARKET, BY REGION

10.2.1.1.      NORTH AMERICA TOPICAL MEDICATIONS MARKET, BY COUNTRY

10.2.1.2.      EUROPE TOPICAL MEDICATIONS MARKET, BY COUNTRY

10.2.1.3.      ASIA-PACIFIC TOPICAL MEDICATIONS MARKET, BY COUNTRY

10.2.1.4.      REST OF WORLD TOPICAL MEDICATIONS MARKET, BY COUNTRY

10.3.        ORAL MEDICATIONS

10.3.1             ORAL MEDICATIONS MARKET, BY REGION

10.3.1.1.      NORTH AMERICA ORAL MEDICATIONS MARKET, BY COUNTRY

10.3.1.2.      EUROPE ORAL MEDICATIONS MARKET, BY COUNTRY

10.3.1.3.      ASIA-PACIFIC ORAL MEDICATIONS MARKET, BY COUNTRY

10.3.1.4.      REST OF WORLD ORAL MEDICATIONS MARKET, BY COUNTRY

11. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET, BY REGION

11.1.        OVERVIEW

11.2.        NORTH AMERICA

11.2.1             NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.2.2             NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.2.3             NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.2.3.1.      NORTH AMERICA RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.2.3.2.      NORTH AMERICA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.2.4             NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.2.5             NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY COUNTRY

11.2.5.1.      U.S.

11.2.5.1.1.       U.S. PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.2.5.1.2.       U.S. PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.2.5.1.3.       U.S. PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.2.5.1.3.1.    U.S. RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.2.5.1.3.2.    U.S. ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.2.5.1.4.       U.S. PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.2.5.2.      CANADA

11.2.5.2.1.       CANADA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.2.5.2.2.       CANADA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.2.5.2.3.       CANADA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.2.5.2.3.1.    CANADA RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.2.5.2.3.2.    CANADA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.2.5.2.4.       CANADA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.2.5.3.      MEXICO

11.2.5.3.1.       MEXICO PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.2.5.3.2.       MEXICO PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.2.5.3.3.       MEXICO PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.2.5.3.3.1.    MEXICO RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.2.5.3.3.2.    MEXICO ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.2.5.3.4.       MEXICO PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.3.        EUROPE

11.3.1             EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.3.2             EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.3.3             EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.3.3.1.      EUROPE RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.3.3.2.      EUROPE ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.3.4             EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.3.5             EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY COUNTRY

11.3.5.1.      UK

11.3.5.1.1.       UK PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.3.5.1.2.       UK PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.3.5.1.3.       UK PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.3.5.1.3.1.    UK RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.3.5.1.3.2.    UK ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.3.5.1.4.       UK PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.3.5.2.      GERMANY

11.3.5.2.1.       GERMANY PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.3.5.2.2.       GERMANY PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.3.5.2.3.       GERMANY PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.3.5.2.3.1.    GERMANY RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.3.5.2.3.2.    GERMANY ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.3.5.2.4.       GERMANY PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.3.5.3.      FRANCE

11.3.5.3.1.       FRANCE PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.3.5.3.2.       FRANCE PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.3.5.3.3.       FRANCE PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.3.5.3.3.1.    FRANCE RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.3.5.3.3.2.    FRANCE ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.3.5.3.4.       FRANCE PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.3.5.4.      SPAIN

11.3.5.4.1.       SPAIN PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.3.5.4.2.       SPAIN PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.3.5.4.3.       SPAIN PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.3.5.4.3.1.    SPAIN RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.3.5.4.3.2.    SPAIN ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.3.5.4.4.       SPAIN PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.3.5.5.      ITALY

11.3.5.5.1.       ITALY PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.3.5.5.2.       ITALY PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.3.5.5.3.       ITALY PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.3.5.5.3.1.    ITALY RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.3.5.5.3.2.    ITALY ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.3.5.5.4.       ITALY PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.3.5.6.      NETHERLANDS

11.3.5.6.1.       NETHERLANDS PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.3.5.6.2.       NETHERLANDS PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.3.5.6.3.       NETHERLANDS PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.3.5.6.3.1.    NETHERLANDS RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.3.5.6.3.2.    NETHERLANDS ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.3.5.6.4.       NETHERLANDS PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.3.5.7.      REST OF EUROPE

11.3.5.7.1.       REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.3.5.7.2.       REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.3.5.7.3.       REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.3.5.7.3.1.    REST OF EUROPE RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.3.5.7.3.2.    REST OF EUROPE ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.3.5.7.4.       REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.4.        ASIA-PACIFIC

11.4.1             ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.4.2             ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.4.3             ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.4.3.1.      ASIA-PACIFIC RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.4.3.2.      ASIA-PACIFIC ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.4.4             ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.4.5             ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY COUNTRY

11.4.5.1.      CHINA

11.4.5.1.1.       CHINA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.4.5.1.2.       CHINA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.4.5.1.3.       CHINA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.4.5.1.3.1.    CHINA RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.4.5.1.3.2.    CHINA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.4.5.1.4.       CHINA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.4.5.2.      JAPAN

11.4.5.2.1.       JAPAN PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.4.5.2.2.       JAPAN PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.4.5.2.3.       JAPAN PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.4.5.2.3.1.    JAPAN RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.4.5.2.3.2.    JAPAN ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.4.5.2.4.       JAPAN PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.4.5.3.      INDIA

11.4.5.3.1.       INDIA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.4.5.3.2.       INDIA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.4.5.3.3.       INDIA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.4.5.3.3.1.    INDIA RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.4.5.3.3.2.    INDIA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.4.5.3.4.       INDIA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.4.5.4.      AUSTRALIA

11.4.5.4.1.       AUSTRALIA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.4.5.4.2.       AUSTRALIA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.4.5.4.3.       AUSTRALIA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.4.5.4.3.1.    AUSTRALIA RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.4.5.4.3.2.    AUSTRALIA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.4.5.4.4.       AUSTRALIA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.4.5.5.      SOUTH KOREA

11.4.5.5.1.       SOUTH KOREA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.4.5.5.2.       SOUTH KOREA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.4.5.5.3.       SOUTH KOREA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.4.5.5.3.1.    SOUTH KOREA RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.4.5.5.3.2.    SOUTH KOREA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.4.5.5.4.       SOUTH KOREA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.4.5.6.      TAIWAN

11.4.5.6.1.       TAIWAN PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.4.5.6.2.       TAIWAN PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.4.5.6.3.       TAIWAN PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.4.5.6.3.1.    TAIWAN RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.4.5.6.3.2.    TAIWAN ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.4.5.6.4.       TAIWAN PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.4.5.7.      VIETNAM

11.4.5.7.1.       VIETNAM PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.4.5.7.2.       VIETNAM PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.4.5.7.3.       VIETNAM PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.4.5.7.3.1.    VIETNAM RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.4.5.7.3.2.    VIETNAM ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.4.5.7.4.       VIETNAM PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.4.5.8.      REST OF ASIA-PACIFIC

11.4.5.8.1.       REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.4.5.8.2.       REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.4.5.8.3.       REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.4.5.8.3.1.    REST OF ASIA-PACIFIC RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.4.5.8.3.2.    REST OF ASIA-PACIFIC ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.4.5.8.4.       REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.5.        REST OF WORLD

11.5.1             REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.5.2             REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.5.3             REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.5.3.1.      REST OF WORLD RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.5.3.2.      REST OF WORLD ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.5.4             REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.5.5             REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET, BY COUNTRY

11.5.5.1.      LATIN AMERICA

11.5.5.1.1.       LATIN AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.5.5.1.2.       LATIN AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.5.5.1.3.       LATIN AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.5.5.1.3.1.    LATIN AMERICA RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.5.5.1.3.2.    LATIN AMERICA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.5.5.1.4.       LATIN AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.5.5.2.      MIDDLE EAST

11.5.5.2.1.       MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.5.5.2.2.       MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.5.5.2.3.       MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.5.5.2.3.1.    MIDDLE EAST RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.5.5.2.3.2.    MIDDLE EAST ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.5.5.2.4.       MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

11.5.5.3.      AFRICA

11.5.5.3.1.       AFRICA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS

11.5.5.3.2.       AFRICA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

11.5.5.3.3.       AFRICA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

11.5.5.3.3.1.    AFRICA RETINOIDS MARKET, BY THERAPEUTIC CLASS

11.5.5.3.3.2.    AFRICA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS

11.5.5.3.4.       AFRICA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

12. COMPANY PROFILES

12.1.        ALMIRALL S.A.

12.1.1             COMPANY OVERVIEW

12.1.2             COMPANY SNAPSHOT

12.1.3             PRODUCT PORTFOLIO

12.1.4             BUSINESS PERFORMANCE

12.1.5             KEY STRATEGIC MOVES & DEVELOPMENTS

12.1.6             PRIMARY MARKET COMPETITORS

12.2.        BAUSCH HEALTH COMPANIES INC.

12.2.1             COMPANY OVERVIEW

12.2.2             COMPANY SNAPSHOT

12.2.3             OPERATING BUSINESS SEGMENTS

12.2.4             PRODUCT PORTFOLIO

12.2.5             BUSINESS PERFORMANCE

12.2.6             SALES BY BUSINESS SEGMENT

12.2.7             SALES BY GEOGRAPHIC SEGMENT

12.2.8             KEY STRATEGIC MOVES & DEVELOPMENTS

12.2.9             PRIMARY MARKET COMPETITORS

12.3.        JOHNSON & JOHNSON

12.3.1             COMPANY OVERVIEW

12.3.2             COMPANY SNAPSHOT

12.3.3             OPERATING BUSINESS SEGMENTS

12.3.4             PRODUCT PORTFOLIO

12.3.5             BUSINESS PERFORMANCE

12.3.6             SALES BY BUSINESS SEGMENT

12.3.7             SALES BY GEOGRAPHIC SEGMENT

12.3.8             KEY STRATEGIC MOVES & DEVELOPMENTS

12.3.9             PRIMARY MARKET COMPETITORS

12.4.        GLAXOSMITHKLINE PLC

12.4.1             COMPANY OVERVIEW

12.4.2             COMPANY SNAPSHOT

12.4.3             OPERATING BUSINESS SEGMENTS

12.4.4             PRODUCT PORTFOLIO

12.4.5             BUSINESS PERFORMANCE

12.4.6             SALES BY BUSINESS SEGMENT

12.4.7             SALES BY GEOGRAPHIC SEGMENT

12.4.8             KEY STRATEGIC MOVES & DEVELOPMENTS

12.4.9             PRIMARY MARKET COMPETITORS

12.5.        GALDERMA

12.5.1             COMPANY OVERVIEW

12.5.2             COMPANY SNAPSHOT

12.5.3             PRODUCT PORTFOLIO

12.5.4             KEY STRATEGIC MOVES & DEVELOPMENTS

12.5.5             PRIMARY MARKET COMPETITORS

12.6.        MAYNE PHARMA GROUP LIMITED

12.6.1             COMPANY OVERVIEW

12.6.2             COMPANY SNAPSHOT

12.6.3             OPERATING BUSINESS SEGMENTS

12.6.4             PRODUCT PORTFOLIO

12.6.5             BUSINESS PERFORMANCE

12.6.6             SALES BY BUSINESS SEGMENT

12.6.7             SALES BY GEOGRAPHIC SEGMENT

12.6.8             KEY STRATEGIC MOVES & DEVELOPMENTS

12.6.9             PRIMARY MARKET COMPETITORS

12.7.        VIATRIS INC.

12.7.1             COMPANY OVERVIEW

12.7.2             COMPANY SNAPSHOT

12.7.3             OPERATING BUSINESS SEGMENTS

12.7.4             PRODUCT PORTFOLIO

12.7.5             BUSINESS PERFORMANCE

12.7.6             OPERATING BUSINESS SEGMENTS

12.7.7             SALES BY BUSINESS SEGMENT

12.7.8             SALES BY GEOGRAPHIC SEGMENT

12.7.9             KEY STRATEGIC MOVES & DEVELOPMENTS

12.7.10          PRIMARY MARKET COMPETITORS

12.8.        SUN PHARMACEUTICAL INDUSTRIES LIMITED

12.8.1             COMPANY OVERVIEW

12.8.2             COMPANY SNAPSHOT

12.8.3             PRODUCT PORTFOLIO

12.8.4             BUSINESS PERFORMANCE

12.8.5             SALES BY BUSINESS SEGMENT

12.8.6             SALES BY GEOGRAPHIC SEGMENT

12.8.7             KEY STRATEGIC MOVES & DEVELOPMENTS

12.8.8             PRIMARY MARKET COMPETITORS

12.9.        PFIZER INC.

12.9.1             COMPANY OVERVIEW

12.9.2             COMPANY SNAPSHOT

12.9.3             OPERATING BUSINESS SEGMENTS

12.9.4             PRODUCT PORTFOLIO

12.9.5             BUSINESS PERFORMANCE

12.9.6             SALES BY BUSINESS SEGMENT

12.9.7             SALES BY GEOGRAPHIC SEGMENT

12.9.8             KEY STRATEGIC MOVES & DEVELOPMENTS

12.9.9             PRIMARY MARKET COMPETITORS

12.10.      TEVA PHARMACEUTICAL INDUSTRIES LTD.

12.10.1          COMPANY OVERVIEW

12.10.2          COMPANY SNAPSHOT

12.10.3          PRODUCT PORTFOLIO

12.10.4          BUSINESS PERFORMANCE

12.10.5          SALES BY BUSINESS SEGMENT

12.10.6          SALES BY GEOGRAPHIC SEGMENT

12.10.7          KEY STRATEGIC MOVES & DEVELOPMENTS

12.10.8          PRIMARY MARKET COMPETITORS

LIST OF TABLES

TABLE 1. TOTAL NUMBER OF MEDICAL SPAS BY COUNTRY

TABLE 2. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 3. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 4. MED SPA MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 5. MED SPA MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 6. NORTH AMERICA MED SPA MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 7. NORTH AMERICA MED SPA MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 8. EUROPE MED SPA MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 9. EUROPE MED SPA MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 10. ASIA-PACIFIC MED SPA MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 11. ASIA-PACIFIC MED SPA MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 12. REST OF WORLD MED SPA MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 13. REST OF WORLD MED SPA MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 14. ESTHETICIANS MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 15. ESTHETICIANS MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 16. NORTH AMERICA ESTHETICIANS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 17. NORTH AMERICA ESTHETICIANS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 18. EUROPE ESTHETICIANS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 19. EUROPE ESTHETICIANS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 20. ASIA-PACIFIC ESTHETICIANS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 21. ASIA-PACIFIC ESTHETICIANS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 22. REST OF WORLD ESTHETICIANS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 23. REST OF WORLD ESTHETICIANS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 24. DERMATOLOGIST MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 25. DERMATOLOGIST MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 26. NORTH AMERICA DERMATOLOGIST MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 27. NORTH AMERICA DERMATOLOGIST MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 28. EUROPE DERMATOLOGIST MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 29. EUROPE DERMATOLOGIST MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 30. ASIA-PACIFIC DERMATOLOGIST MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 31. ASIA-PACIFIC DERMATOLOGIST MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 32. REST OF WORLD DERMATOLOGIST MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 33. REST OF WORLD DERMATOLOGIST MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 34. OTHER PROFESSIONAL CHANNELS MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 35. OTHER PROFESSIONAL CHANNELS MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 36. NORTH AMERICA OTHER PROFESSIONAL CHANNELS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 37. NORTH AMERICA OTHER PROFESSIONAL CHANNELS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 38. EUROPE OTHER PROFESSIONAL CHANNELS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 39. EUROPE OTHER PROFESSIONAL CHANNELS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 40. ASIA-PACIFIC OTHER PROFESSIONAL CHANNELS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 41. ASIA-PACIFIC OTHER PROFESSIONAL CHANNELS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 42. REST OF WORLD OTHER PROFESSIONAL CHANNELS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 43. REST OF WORLD OTHER PROFESSIONAL CHANNELS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 44. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 45. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 46. INFLAMMATORY ACNE MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 47. INFLAMMATORY ACNE MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 48. NORTH AMERICA INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 49. NORTH AMERICA INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 50. EUROPE INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 51. EUROPE INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 52. ASIA-PACIFIC INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 53. ASIA-PACIFIC INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 54. REST OF WORLD INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 55. REST OF WORLD INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 56. NON-INFLAMMATORY ACNE MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 57. NON-INFLAMMATORY ACNE MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 58. NORTH AMERICA NON-INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 59. NORTH AMERICA NON-INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 60. EUROPE NON-INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 61. EUROPE NON-INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 62. ASIA-PACIFIC NON-INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 63. ASIA-PACIFIC NON-INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 64. REST OF WORLD NON-INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 65. REST OF WORLD NON-INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 66. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 67. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 68. GLOBAL RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 69. GLOBAL RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 70. TOPICAL RETINOID & COMBINATION RETIONOID  MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 71. TOPICAL RETINOID & COMBINATION RETIONOID  MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 72. NORTH AMERICA TOPICAL RETINOID & COMBINATION RETIONOID  MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 73. NORTH AMERICA TOPICAL RETINOID & COMBINATION RETIONOID  MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 74. EUROPE TOPICAL RETINOID & COMBINATION RETIONOID  MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 75. EUROPE TOPICAL RETINOID & COMBINATION RETIONOID  MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 76. ASIA-PACIFIC TOPICAL RETINOID & COMBINATION RETIONOID  MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 77. ASIA-PACIFIC TOPICAL RETINOID & COMBINATION RETIONOID  MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 78. REST OF WORLD TOPICAL RETINOID & COMBINATION RETIONOID  MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 79. REST OF WORLD TOPICAL RETINOID & COMBINATION RETIONOID  MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 80. ORAL RETINOID (ISORETINION) MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 81. ORAL RETINOID (ISORETINION) MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 82. NORTH AMERICA ORAL RETINOID (ISORETINION) MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 83. NORTH AMERICA ORAL RETINOID (ISORETINION) MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 84. EUROPE ORAL RETINOID (ISORETINION) MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 85. EUROPE ORAL RETINOID (ISORETINION) MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 86. ASIA-PACIFIC ORAL RETINOID (ISORETINION) MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 87. ASIA-PACIFIC ORAL RETINOID (ISORETINION) MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 88. REST OF WORLD ORAL RETINOID (ISORETINION) MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 89. REST OF WORLD ORAL RETINOID (ISORETINION) MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 90. RETINOIDS MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 91. RETINOIDS MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 92. NORTH AMERICA RETINOIDS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 93. NORTH AMERICA RETINOIDS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 94. EUROPE RETINOIDS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 95. EUROPE RETINOIDS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 96. ASIA-PACIFIC RETINOIDS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 97. ASIA-PACIFIC RETINOIDS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 98. REST OF WORLD RETINOIDS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 99. REST OF WORLD RETINOIDS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 100. GLOBAL ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 101. GLOBAL ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 102. TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 103. TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 104. NORTH AMERICA TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 105. NORTH AMERICA TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 106. EUROPE TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 107. EUROPE TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 108. ASIA-PACIFIC TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 109. ASIA-PACIFIC TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 110. REST OF WORLD TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 111. REST OF WORLD TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 112. ORAL ANTIBIOTIC  MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 113. ORAL ANTIBIOTIC  MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 114. NORTH AMERICA ORAL ANTIBIOTIC  MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 115. NORTH AMERICA ORAL ANTIBIOTIC  MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 116. EUROPE ORAL ANTIBIOTIC  MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 117. EUROPE ORAL ANTIBIOTIC  MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 118. ASIA-PACIFIC ORAL ANTIBIOTIC  MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 119. ASIA-PACIFIC ORAL ANTIBIOTIC  MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 120. REST OF WORLD ORAL ANTIBIOTIC  MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 121. REST OF WORLD ORAL ANTIBIOTIC  MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 122. ANTIBIOTICS MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 123. ANTIBIOTICS MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 124. NORTH AMERICA ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 125. NORTH AMERICA ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 126. EUROPE ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 127. EUROPE ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 128. ASIA-PACIFIC ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 129. ASIA-PACIFIC ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 130. REST OF WORLD ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 131. REST OF WORLD ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 132. SALICYLIC ACID MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 133. SALICYLIC ACID MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 134. NORTH AMERICA SALICYLIC ACID MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 135. NORTH AMERICA SALICYLIC ACID MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 136. EUROPE SALICYLIC ACID MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 137. EUROPE SALICYLIC ACID MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 138. ASIA-PACIFIC SALICYLIC ACID MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 139. ASIA-PACIFIC SALICYLIC ACID MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 140. REST OF WORLD SALICYLIC ACID MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 141. REST OF WORLD SALICYLIC ACID MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 142. BENZOYL PEROXIDE MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 143. BENZOYL PEROXIDE MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 144. NORTH AMERICA BENZOYL PEROXIDE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 145. NORTH AMERICA BENZOYL PEROXIDE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 146. EUROPE BENZOYL PEROXIDE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 147. EUROPE BENZOYL PEROXIDE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 148. ASIA-PACIFIC BENZOYL PEROXIDE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 149. ASIA-PACIFIC BENZOYL PEROXIDE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 150. REST OF WORLD BENZOYL PEROXIDE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 151. REST OF WORLD BENZOYL PEROXIDE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 152. OTHERS MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 153. OTHERS MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 154. NORTH AMERICA OTHERS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 155. NORTH AMERICA OTHERS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 156. EUROPE OTHERS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 157. EUROPE OTHERS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 158. ASIA-PACIFIC OTHERS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 159. ASIA-PACIFIC OTHERS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 160. REST OF WORLD OTHERS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 161. REST OF WORLD OTHERS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 162. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 163. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 164. TOPICAL MEDICATIONS MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 165. TOPICAL MEDICATIONS MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 166. NORTH AMERICA TOPICAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 167. NORTH AMERICA TOPICAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 168. EUROPE TOPICAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 169. EUROPE TOPICAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 170. ASIA-PACIFIC TOPICAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 171. ASIA-PACIFIC TOPICAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 172. REST OF WORLD TOPICAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 173. REST OF WORLD TOPICAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 174. ORAL MEDICATIONS MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 175. ORAL MEDICATIONS MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 176. NORTH AMERICA ORAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 177. NORTH AMERICA ORAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 178. EUROPE ORAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 179. EUROPE ORAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 180. ASIA-PACIFIC ORAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 181. ASIA-PACIFIC ORAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 182. REST OF WORLD ORAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 183. REST OF WORLD ORAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 184. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY REGION, 2020-2025, MILLION USD

TABLE 185. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY REGION, 2026-2030, MILLION USD

TABLE 186. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 187. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 188. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 189. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 190. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 191. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 192. NORTH AMERICA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 193. NORTH AMERICA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 194. NORTH AMERICA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 195. NORTH AMERICA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 196. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 197. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 198. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 199. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 200. U.S. PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 201. U.S. PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 202. U.S. PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 203. U.S. PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 204. U.S. PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 205. U.S. PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 206. U.S. RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 207. U.S. RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 208. U.S. ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 209. U.S. ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 210. U.S. PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 211. U.S. PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 212. CANADA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 213. CANADA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 214. CANADA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 215. CANADA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 216. CANADA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 217. CANADA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 218. CANADA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 219. CANADA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 220. CANADA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 221. CANADA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 222. CANADA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 223. CANADA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 224. MEXICO PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 225. MEXICO PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 226. MEXICO PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 227. MEXICO PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 228. MEXICO PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 229. MEXICO PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 230. MEXICO RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 231. MEXICO RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 232. MEXICO ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 233. MEXICO ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 234. MEXICO PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 235. MEXICO PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 236. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 237. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 238. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 239. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 240. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 241. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 242. EUROPE RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 243. EUROPE RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 244. EUROPE ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 245. EUROPE ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 246. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 247. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 248. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 249. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 250. UK PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 251. UK PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 252. UK PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 253. UK PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 254. UK PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 255. UK PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 256. UK RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 257. UK RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 258. UK ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 259. UK ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 260. UK PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 261. UK PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 262. GERMANY PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 263. GERMANY PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 264. GERMANY PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 265. GERMANY PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 266. GERMANY PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 267. GERMANY PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 268. GERMANY RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 269. GERMANY RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 270. GERMANY ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 271. GERMANY ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 272. GERMANY PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 273. GERMANY PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 274. FRANCE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 275. FRANCE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 276. FRANCE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 277. FRANCE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 278. FRANCE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 279. FRANCE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 280. FRANCE RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 281. FRANCE RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 282. FRANCE ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 283. FRANCE ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 284. FRANCE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 285. FRANCE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 286. SPAIN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 287. SPAIN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 288. SPAIN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 289. SPAIN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 290. SPAIN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 291. SPAIN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 292. SPAIN RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 293. SPAIN RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 294. SPAIN ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 295. SPAIN ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 296. SPAIN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 297. SPAIN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 298. ITALY PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 299. ITALY PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 300. ITALY PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 301. ITALY PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 302. ITALY PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 303. ITALY PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 304. ITALY RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 305. ITALY RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 306. ITALY ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 307. ITALY ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 308. ITALY PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 309. ITALY PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 310. NETHERLANDS PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 311. NETHERLANDS PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 312. NETHERLANDS PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 313. NETHERLANDS PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 314. NETHERLANDS PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 315. NETHERLANDS PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 316. NETHERLANDS RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 317. NETHERLANDS RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 318. NETHERLANDS ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 319. NETHERLANDS ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 320. NETHERLANDS PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 321. NETHERLANDS PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 322. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 323. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 324. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 325. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 326. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 327. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 328. REST OF EUROPE RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 329. REST OF EUROPE RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 330. REST OF EUROPE ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 331. REST OF EUROPE ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 332. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 333. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 334. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 335. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 336. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 337. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 338. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 339. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 340. ASIA-PACIFIC RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 341. ASIA-PACIFIC RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 342. ASIA-PACIFIC ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 343. ASIA-PACIFIC ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 344. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 345. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 346. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 347. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 348. CHINA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 349. CHINA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 350. CHINA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 351. CHINA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 352. CHINA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 353. CHINA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 354. CHINA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 355. CHINA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 356. CHINA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 357. CHINA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 358. CHINA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 359. CHINA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 360. JAPAN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 361. JAPAN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 362. JAPAN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 363. JAPAN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 364. JAPAN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 365. JAPAN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 366. JAPAN RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 367. JAPAN RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 368. JAPAN ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 369. JAPAN ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 370. JAPAN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 371. JAPAN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 372. INDIA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 373. INDIA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 374. INDIA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 375. INDIA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 376. INDIA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 377. INDIA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 378. INDIA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 379. INDIA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 380. INDIA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 381. INDIA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 382. INDIA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 383. INDIA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 384. AUSTRALIA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 385. AUSTRALIA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 386. AUSTRALIA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 387. AUSTRALIA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 388. AUSTRALIA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 389. AUSTRALIA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 390. AUSTRALIA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 391. AUSTRALIA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 392. AUSTRALIA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 393. AUSTRALIA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 394. AUSTRALIA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 395. AUSTRALIA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 396. SOUTH KOREA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 397. SOUTH KOREA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 398. SOUTH KOREA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 399. SOUTH KOREA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 400. SOUTH KOREA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 401. SOUTH KOREA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 402. SOUTH KOREA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 403. SOUTH KOREA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 404. SOUTH KOREA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 405. SOUTH KOREA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 406. SOUTH KOREA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 407. SOUTH KOREA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 408. TAIWAN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 409. TAIWAN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 410. TAIWAN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 411. TAIWAN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 412. TAIWAN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 413. TAIWAN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 414. TAIWAN RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 415. TAIWAN RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 416. TAIWAN ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 417. TAIWAN ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 418. TAIWAN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 419. TAIWAN PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 420. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 421. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 422. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 423. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 424. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 425. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 426. VIETNAM RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 427. VIETNAM RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 428. VIETNAM ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 429. VIETNAM ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 430. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 431. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 432. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 433. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 434. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 435. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 436. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 437. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 438. REST OF ASIA-PACIFIC RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 439. REST OF ASIA-PACIFIC RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 440. REST OF ASIA-PACIFIC ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 441. REST OF ASIA-PACIFIC ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 442. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 443. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 444. REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 445. REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 446. REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 447. REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 448. REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 449. REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 450. REST OF WORLD RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 451. REST OF WORLD RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 452. REST OF WORLD ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 453. REST OF WORLD ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 454. REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 455. REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 456. REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD

TABLE 457. REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD

TABLE 458. LATIN AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 459. LATIN AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 460. LATIN AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 461. LATIN AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 462. LATIN AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 463. LATIN AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 464. LATIN AMERICA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 465. LATIN AMERICA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 466. LATIN AMERICA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 467. LATIN AMERICA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 468. LATIN AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 469. LATIN AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 470. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 471. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 472. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 473. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 474. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 475. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 476. MIDDLE EAST RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 477. MIDDLE EAST RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 478. MIDDLE EAST ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 479. MIDDLE EAST ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 480. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 481. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 482. AFRICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2025, MILLION USD

TABLE 483. AFRICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2026-2030, MILLION USD

TABLE 484. AFRICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2025, MILLION USD

TABLE 485. AFRICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2026-2030, MILLION USD

TABLE 486. AFRICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 487. AFRICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 488. AFRICA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 489. AFRICA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 490. AFRICA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2025, MILLION USD

TABLE 491. AFRICA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2026-2030, MILLION USD

TABLE 492. AFRICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2025, MILLION USD

TABLE 493. AFRICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2026-2030, MILLION USD

TABLE 494. ALMIRALL S.A.: COMPANY SNAPSHOT

TABLE 495. ALMIRALL S.A.: PRODUCT PORTFOLIO

TABLE 496. ALMIRALL S.A.: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 497. BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT

TABLE 498. BAUSCH HEALTH COMPANIES INC.: OPERATING SEGMENTS

TABLE 499. BAUSCH HEALTH COMPANIES INC.: PRODUCT PORTFOLIO

TABLE 500. BAUSCH HEALTH COMPANIES INC.: BUSINESS SEGMENT

TABLE 501. BAUSCH HEALTH COMPANIES INC.: GEOGRAPHIC SEGMENT

TABLE 502. BAUSCH HEALTH COMPANIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

TABLE 503. JOHNSON & JOHNSON: COMPANY SNAPSHOT

TABLE 504. JOHNSON & JOHNSON: OPERATING SEGMENTS

TABLE 505. JOHNSON & JOHNSON: PRODUCT PORTFOLIO

TABLE 506. JOHNSON & JOHNSON: BUSINESS SEGMENT

TABLE 507. JOHNSON & JOHNSON: GEOGRAPHIC SEGMENT

TABLE 508. JOHNSON & JOHNSON: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 509. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT

TABLE 510. GLAXOSMITHKLINE PLC : OPERATING SEGMENTS

TABLE 511. GLAXOSMITHKLINE PLC.: PRODUCT PORTFOLIO

TABLE 512. GLAXOSMITHKLINE PLC.: BUSINESS SEGMENT

TABLE 513. GLAXOSMITHKLINE PLC.: GEOGRAPHIC SEGMENT

TABLE 514. GLAXOSMITHKLINE PLC.: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 515. GALDERMA: COMPANY SNAPSHOT

TABLE 516. GALDERMA.: PRODUCT PORTFOLIO

TABLE 517. GALDERMA.: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 518. MAYNE PHARMA GROUP LIMITED: COMPANY SNAPSHOT

TABLE 519. MAYNE PHARMA GROUP LIMITED: OPERATING SEGMENTS

TABLE 520. MAYNE PHARMA GROUP LIMITED: PRODUCT PORTFOLIO

TABLE 521. MAYNE PHARMA GROUP LIMITED: BUSINESS SEGMENT

TABLE 522. MAYNE PHARMA GROUP LIMITED: GEOGRAPHIC SEGMENT

TABLE 523. MAYNE PHARMA GROUP LIMITED: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 524. VIATRIS INC.: COMPANY SNAPSHOT

TABLE 525. VIATRIS INC.: OPERATING SEGMENTS

TABLE 526. VIATRIS INC.: PRODUCT PORTFOLIO

TABLE 527. VIATRIS INC.: OPERATING SEGMENTS

TABLE 528. VIATRIS INC.: BUSINESS SEGMENT

TABLE 529. VIATRIS INC.: GEOGRAPHIC SEGMENT

TABLE 530. VIATRIS INC.: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 531. SUN PHARMACEUTICAL INDUSTRIES LIMITED: COMPANY SNAPSHOT

TABLE 532. SUN PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCT PORTFOLIO

TABLE 533. SUN PHARMACEUTICAL INDUSTRIES LIMITED: BUSINESS SEGMENT

TABLE 534. PFIZER INC.: COMPANY SNAPSHOT

TABLE 535. PFIZER INC.: OPERATING SEGMENTS

TABLE 536. PFIZER INC.: PRODUCT PORTFOLIO

TABLE 537. PFIZER INC.: BUSINESS SEGMENT

TABLE 538. TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT

TABLE 539. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO

TABLE 540. TEVA PHARMACEUTICAL INDUSTRIES LTD.: BUSINESS SEGMENT

TABLE 541. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATEGIC MOVES & DEVELOPMENTS

LIST OF FIGURES

FIGURE 1. MARKET SHARE ANALYSIS OF TOP ACNE MEDICATION PROVIDERS, 2020

FIGURE 2. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 3. MED SPA MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 4. NORTH AMERICA MED SPA MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 5. EUROPE MED SPA MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 6. ASIA-PACIFIC MED SPA MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 7. REST OF WORLD MED SPA MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 8. ESTHETICIANS MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 9. NORTH AMERICA ESTHETICIANS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 10. EUROPE ESTHETICIANS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 11. ASIA-PACIFIC ESTHETICIANS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 12. REST OF WORLD ESTHETICIANS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 13. DERMATOLOGIST MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 14. NORTH AMERICA DERMATOLOGIST MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 15. EUROPE DERMATOLOGIST MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 16. ASIA-PACIFIC DERMATOLOGIST MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 17. REST OF WORLD DERMATOLOGIST MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 18. OTHER PROFESSIONAL CHANNELS MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 19. NORTH AMERICA OTHER PROFESSIONAL CHANNELS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 20. EUROPE OTHER PROFESSIONAL CHANNELS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 21. ASIA-PACIFIC OTHER PROFESSIONAL CHANNELS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 22. REST OF WORLD OTHER PROFESSIONAL CHANNELS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 23. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 24. INFLAMMATORY ACNE MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 25. NORTH AMERICA INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 26. EUROPE INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 27. ASIA-PACIFIC INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 28. REST OF WORLD INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 29. NON-INFLAMMATORY ACNE MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 30. NORTH AMERICA NON-INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 31. EUROPE NON-INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 32. ASIA-PACIFIC NON-INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 33. REST OF WORLD NON-INFLAMMATORY ACNE MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 34. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 35. GLOBAL RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 36. TOPICAL RETINOID & COMBINATION RETIONOID  MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 37. NORTH AMERICA TOPICAL RETINOID & COMBINATION RETIONOID  MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 38. EUROPE TOPICAL RETINOID & COMBINATION RETIONOID  MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 39. ASIA-PACIFIC TOPICAL RETINOID & COMBINATION RETIONOID  MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 40. REST OF WORLD TOPICAL RETINOID & COMBINATION RETIONOID  MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 41. ORAL RETINOID (ISORETINION) MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 42. NORTH AMERICA ORAL RETINOID (ISORETINION) MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 43. EUROPE ORAL RETINOID (ISORETINION) MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 44. ASIA-PACIFIC ORAL RETINOID (ISORETINION) MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 45. REST OF WORLD ORAL RETINOID (ISORETINION) MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 46. RETINOIDS MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 47. NORTH AMERICA RETINOIDS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 48. EUROPE RETINOIDS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 49. ASIA-PACIFIC RETINOIDS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 50. REST OF WORLD RETINOIDS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 51. GLOBAL ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 52. TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 53. NORTH AMERICA TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 54. EUROPE TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 55. ASIA-PACIFIC TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 56. REST OF WORLD TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 57. ORAL ANTIBIOTIC  MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 58. NORTH AMERICA ORAL ANTIBIOTIC  MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 59. EUROPE ORAL ANTIBIOTIC  MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 60. ASIA-PACIFIC ORAL ANTIBIOTIC  MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 61. REST OF WORLD ORAL ANTIBIOTIC  MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 62. ANTIBIOTICS MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 63. NORTH AMERICA ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 64. EUROPE ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 65. ASIA-PACIFIC ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 66. REST OF WORLD ANTIBIOTICS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 67. SALICYLIC ACID MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 68. NORTH AMERICA SALICYLIC ACID MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 69. EUROPE SALICYLIC ACID MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 70. ASIA-PACIFIC SALICYLIC ACID MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 71. REST OF WORLD SALICYLIC ACID MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 72. BENZOYL PEROXIDE MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 73. NORTH AMERICA BENZOYL PEROXIDE MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 74. EUROPE BENZOYL PEROXIDE MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 75. ASIA-PACIFIC BENZOYL PEROXIDE MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 76. REST OF WORLD BENZOYL PEROXIDE MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 77. OTHERS MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 78. NORTH AMERICA OTHERS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 79. EUROPE OTHERS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 80. ASIA-PACIFIC OTHERS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 81. REST OF WORLD OTHERS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 82. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 83. TOPICAL MEDICATIONS MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 84. NORTH AMERICA TOPICAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 85. EUROPE TOPICAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 86. ASIA-PACIFIC TOPICAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 87. REST OF WORLD TOPICAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 88. ORAL MEDICATIONS MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 89. NORTH AMERICA ORAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 90. EUROPE ORAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 91. ASIA-PACIFIC ORAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 92. REST OF WORLD ORAL MEDICATIONS MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 93. GLOBAL PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY REGION, 2020-2030, MILLION USD

FIGURE 94. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 95. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 96. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 97. NORTH AMERICA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 98. NORTH AMERICA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 99. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 100. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 101. U.S. PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 102. U.S. PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 103. U.S. PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 104. U.S. RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 105. U.S. ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 106. U.S. PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 107. CANADA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 108. CANADA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 109. CANADA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 110. CANADA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 111. CANADA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 112. CANADA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 113. MEXICO PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 114. MEXICO PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 115. MEXICO PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 116. MEXICO RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 117. MEXICO ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 118. MEXICO PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 119. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 120. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 121. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 122. EUROPE RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 123. EUROPE ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 124. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 125. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 126. UK PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 127. UK PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 128. UK PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 129. UK RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 130. UK ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 131. UK PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 132. GERMANY PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 133. GERMANY PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 134. GERMANY PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 135. GERMANY RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 136. GERMANY ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 137. GERMANY PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 138. FRANCE PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 139. FRANCE PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 140. FRANCE PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 141. FRANCE RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 142. FRANCE ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 143. FRANCE PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 144. SPAIN PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 145. SPAIN PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 146. SPAIN PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 147. SPAIN RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 148. SPAIN ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 149. SPAIN PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 150. ITALY PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 151. ITALY PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 152. ITALY PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 153. ITALY RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 154. ITALY ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 155. ITALY PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 156. NETHERLANDS PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 157. NETHERLANDS PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 158. NETHERLANDS PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 159. NETHERLANDS RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 160. NETHERLANDS ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 161. NETHERLANDS PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 162. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 163. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 164. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 165. REST OF EUROPE RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 166. REST OF EUROPE ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 167. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 168. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 169. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 170. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 171. ASIA-PACIFIC RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 172. ASIA-PACIFIC ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 173. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 174. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 175. CHINA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 176. CHINA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 177. CHINA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 178. CHINA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 179. CHINA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 180. CHINA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 181. JAPAN PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 182. JAPAN PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 183. JAPAN PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 184. JAPAN RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 185. JAPAN ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 186. JAPAN PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 187. INDIA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 188. INDIA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 189. INDIA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 190. INDIA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 191. INDIA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 192. INDIA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 193. AUSTRALIA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 194. AUSTRALIA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 195. AUSTRALIA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 196. AUSTRALIA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 197. AUSTRALIA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 198. AUSTRALIA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 199. SOUTH KOREA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 200. SOUTH KOREA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 201. SOUTH KOREA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 202. SOUTH KOREA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 203. SOUTH KOREA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 204. SOUTH KOREA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 205. TAIWAN PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 206. TAIWAN PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 207. TAIWAN PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 208. TAIWAN RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 209. TAIWAN ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 210. TAIWAN PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 211. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 212. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 213. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 214. VIETNAM RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 215. VIETNAM ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 216. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 217. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 218. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 219. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 220. REST OF ASIA-PACIFIC RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 221. REST OF ASIA-PACIFIC ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 222. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 223. REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 224. REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 225. REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 226. REST OF WORLD RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 227. REST OF WORLD ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 228. REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 229. REST OF WORLD PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY COUNTRY, 2020-2030, MILLION USD

FIGURE 230. LATIN AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 231. LATIN AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 232. LATIN AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 233. LATIN AMERICA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 234. LATIN AMERICA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 235. LATIN AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 236. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 237. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 238. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 239. MIDDLE EAST RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 240. MIDDLE EAST ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 241. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 242. AFRICA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNELS, 2020-2030, MILLION USD

FIGURE 243. AFRICA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2020-2030, MILLION USD

FIGURE 244. AFRICA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 245. AFRICA RETINOIDS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 246. AFRICA ANTIBIOTICS MARKET VALUE, BY THERAPEUTIC CLASS, 2020-2030, MILLION USD

FIGURE 247. AFRICA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION, 2020-2030, MILLION USD

FIGURE 248. ALMIRALL S.A.: NET SALES, 2018–2020 ($MILLION)

FIGURE 249. ALMIRALL S.A..: PRIMARY MARKET COMPETITORS

FIGURE 250. BAUSCH HEALTH COMPANIES INC.: NET SALES, 2018–2020 ($MILLION)

FIGURE 251. BAUSCH HEALTH COMPANIES INC.: PRIMARY MARKET COMPETITORS

FIGURE 252. JOHNSON & JOHNSON : NET SALES, 2018–2020 ($MILLION)

FIGURE 253. JOHNSON & JOHNSON.: PRIMARY MARKET COMPETITORS

FIGURE 254. GLAXOSMITHKLINE PLC : NET SALES, 2018–2020 ($MILLION)

FIGURE 255. GLAXOSMITHKLINE PLC.: PRIMARY MARKET COMPETITORS

FIGURE 256. GALDERMA.: PRIMARY MARKET COMPETITORS

FIGURE 257. MAYNE PHARMA GROUP LIMITED: NET SALES, 2018–2020 ($MILLION)

FIGURE 258. MAYNE PHARMA GROUP LIMITED.: PRIMARY MARKET COMPETITORS

FIGURE 259. VIATRIS INC.: NET SALES, 2018–2020 ($MILLION)

FIGURE 260. VIATRIS INC.: PRIMARY MARKET COMPETITORS

FIGURE 261. SUN PHARMACEUTICAL INDUSTRIES LIMITED: NET SALES, 2018–2020 ($MILLION)

FIGURE 262. SUN PHARMACEUTICAL INDUSTRIES LIMITED.: PRIMARY MARKET COMPETITORS

FIGURE 263. PFIZER INC.: NET SALES, 2018–2020 ($MILLION)

FIGURE 264. PFIZER INC.: PRIMARY MARKET COMPETITORS

FIGURE 265. TEVA PHARMACEUTICAL INDUSTRIES LTD.: NET SALES, 2018–2020 ($MILLION)

FIGURE 266. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRIMARY MARKET COMPETITORS

 

At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.

Research Landscape

We navigate the world of research with two primary approaches:

Qualitative Approach

Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.

Quantitative Research

In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.

Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.

Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.

 

Our Specialized Toolbox for Industry-Specific Market Research

We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:

Information Procurement

The stage entails acquiring market data or relevant information through various sources and methodologies.

Market Research Approach

We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.

Porters Five Forces Analysis

We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.

              

SWOT Analysis

We conduct SWOT analysis to understand market trends, identify potential threats, capitalize on opportunities, and assess our strengths and weaknesses.

Forecasting

We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.